Discovery of enzyme in the sleeping sickness parasite streamlines drug development

(Umea University) Researchers from Umeå University in Sweden have discovered that the single-celled parasite causing African sleeping sickness has a defense mechanism against potential pharmaceuticals under development against the disease. The deadly parasite has an enzyme that can cleave and hence disarm adenosine analogue pharmaceuticals. This according to a study recently published in the Journal of Biological Chemistry.